Reversal of gene dysregulation in cultured cytotrophoblasts reveals possible causes of preeclampsia

Journal of Clinical Investigation

Volumn 123, Issue 7, 2013, Pages 2862-2872

  Zhou, Yan ^a,b   Gormley, Matthew J ^a,b   Hunkapiller, Nathan M ^a,b   Kapidzic, Mirhan ^a,b   Stolyarov, Yana ^a,b   Feng, Victoria ^a,b   Nishida, Masakazu ^a,b   Drake, Penelope M ^a,b   Bianco, Katherine ^a,b   Wang, Fei ^a,b,c   McMaster, Michael T ^a,b   Fisher, Susan J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL INVASION; CYTOTROPHOBLAST; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PHENOTYPE; PREECLAMPSIA; PRIORITY JOURNAL; TRANSCRIPTOMICS; UPREGULATION;

ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; CELL MOVEMENT; CERCOPITHECUS AETHIOPS; CHICK EMBRYO; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; COS CELLS; FEMALE; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MEMBRANE GLYCOPROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NEUROPILIN-1; NEUROPILIN-2; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SEMAPHORINS; SIGNAL TRANSDUCTION; TRANSCRIPTOME; TROPHOBLASTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84879640836     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI66966     Document Type: Article

References (65)

1. Maltepe E, Bakardjiev AI, Fisher SJ. The placenta: transcriptional, epigenetic, and physiological integration during development. J Clin Invest. 2010;120(4):1016-1025.
2. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta. 2006;27(9-10):939-958. (Pubitemid 44204033)
3. Zhou Y, et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest. 1997;99(9):2139-2151. (Pubitemid 27203770)
4. Red-Horse K, Kapidzic M, Zhou Y, Feng KT, Singh H, Fisher SJ. EPHB4 regulates chemokine-evoked trophoblast responses: a mechanism for incorporating the human placenta into the maternal circulation. Development. 2005;132(18):4097-4106. (Pubitemid 41488859)
5. Hunkapiller NM, et al. A role for Notch signaling in trophoblast endovascular invasion and in the pathogenesis of pre-eclampsia. Development. 2011;138(14):2987-2998.
6. Zhou Y, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002;160(4):1405-1423. (Pubitemid 34411644)
7. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592-1594. (Pubitemid 40807500)
8. Gebb J, Dar P. Colour Doppler ultrasound of spiral artery blood flow in the prediction of pre-eclampsia and intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol. 2011;25(3):355-366.
9. Naicker T, Khedun SM, Moodley J, Pijnenborg R. Quantitative analysis of trophoblast invasion in preeclampsia. Acta Obstet Gynecol Scand. 2003;82(8):722-729. (Pubitemid 36898050)
10. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu. 1972;1:177-191.
11. Zhou Y, Damsky CH, Chiu K, Roberts JM, Fisher SJ. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest. 1993;91(3):950-960. (Pubitemid 23095269)
12. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest. 1997;99(9):2152-2164. (Pubitemid 27203771)
13. DiFederico E, Genbacev O, Fisher SJ. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol. 1999;155(1):293-301. (Pubitemid 29318727)
14. Maynard SE, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649-658.
15. Venkatesha S, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12(6):642-649. (Pubitemid 43865232)
16. Li M, Yee D, Magnuson TR, Smithies O, Caron KM. Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice. J Clin Invest. 2006;116(10):2653-2662. (Pubitemid 44511629)
17. Zhou Y, et al. Comparative analysis of maternal-fetal interface in preeclampsia and preterm labor. Cell Tissue Res. 2007;329(3):559-569. (Pubitemid 47231293)
18. ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number. 2002;77:67-75.
19. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A Review. BMC Pregnancy Childbirth. 2009;9:8.
20. Mittal P, et al. Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia. J Matern Fetal Neonatal Med. 2007;20(9):651-659. (Pubitemid 47262701)
21. Winn VD, et al. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology. 2009;150(1):452-462.
22. Zhang H, Long Q, Ling L, Gao A, Li H, Lin Q. Elevated expression of KiSS-1 in placenta of preeclampsia and its effect on trophoblast. Reprod Biol. 2011;11(2):99-115.
23. Gack S, et al. Preeclampsia: increased expression of soluble ADAM 12. J Mol Med (Berl). 2005;83(11):887-896. (Pubitemid 41598689)
24. Kolodkin AL, Tessier-Lavigne M. Mechanisms and molecules of neuronal wiring: a primer. Cold Spring Harb Perspect Biol. 2011;3(6).pii: a001727.
25. Castro-Rivera E, Ran S, Brekken RA, Minna JD. Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells. Cancer Res. 2008;68(20):8295-8303.
26. Dayanir V, Meyer RD, Lashkari K, Rahimi N. Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. J Biol Chem. 2001;276(21):17686-17692.
27. Datta SR, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997;91(2):231-241. (Pubitemid 27456390)
28. Kandel ES, Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res. 1999;253(1):210-229.
29. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995;378(6559):785-789. (Pubitemid 26004411)
30. Shaw M, Cohen P, Alessi DR. Further evidence that the inhibition of glycogen synthase kinase-3beta by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett. 1997;416(3):307-311. (Pubitemid 27475387)
31. Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci. 2003;116(pt 7):1175-1186. (Pubitemid 36410657)
32. Zucman-Rossi J, et al. Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas. Oncogene. 2007;26(5):774-780. (Pubitemid 46204256)
33. Daugherty RL, Gottardi CJ. Phospho-regulation of Beta-catenin adhesion and signaling functions. Physiology (Bethesda). 2007;22:303-309.
34. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123(24):2856-2869.
35. Lacroix MC, et al. Stimulation of human trophoblast invasion by placental growth hormone. Endocrinology. 2005;146(5):2434-2444.
36. Hiden U, Bilban M, Knofler M, Desoye G. Kisspeptins and the placenta: regulation of trophoblast invasion. Rev Endocr Metab Disord. 2007;8(1):31-39. (Pubitemid 46536847)
37. Takeda N, Jain R, LeBoeuf MR, Wang Q, Lu MM, Epstein JA. Interconversion between intestinal stem cell populations in distinct niches. Science. 2011;334(6061):1420-1424.
38. Trivedi CM, et al. Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferation. Dev Cell. 2010;19(3):450-459.
39. Genbacev O, et al. Establishment of human trophoblast progenitor cell lines from the chorion. Stem Cells. 2011;29(9):1427-1436.
40. Asanoma K, et al. HOP/NECC1, a novel regulator of mouse trophoblast differentiation. J Biol Chem. 2007;282(33):24065-24074. (Pubitemid 47328046)
41. Mii Y, Taira M. Secreted Wnt "inhibitors" are not just inhibitors: regulation of extracellular Wnt by secreted Frizzled-related proteins. Dev Growth Differ. 2011;53(8):911-923.
42. Rawn SM, Cross JC. The evolution, regulation, and function of placenta-specific genes. Annu Rev Cell Dev Biol. 2008;24:159-181.
43. Fant M, Farina A, Nagaraja R, Schlessinger D. PLAC1 (Placenta-specific 1): a novel, X-linked gene with roles in reproductive and cancer biology. Prenat Diagn. 2010;30(6):497-502.
44. Ha CT, et al. Human pregnancy specific beta-1-glycoprotein 1 (PSG1) has a potential role in placental vascular morphogenesis. Biol Reprod. 2010;83(1):27-35.
45. Lisboa FA, et al. Pregnancy-specific glycoprotein 1 induces endothelial tubulogenesis through interaction with cell surface proteoglycans. J Biol Chem. 2011;286(9):7577-7586.
46. Motran CC, Diaz FL, Gruppi A, Slavin D, Chatton B, Bocco JL. Human pregnancy-specific glycoprotein 1a (PSG1a) induces alternative activation in human and mouse monocytes and suppresses the accessory cell-dependent T cell proliferation. J Leukoc Biol. 2002;72(3):512-521.
47. Snyder SK, et al. Pregnancy-specific glycoproteins function as immunomodulators by inducing secretion of IL-10, IL-6 and TGF-beta1 by human monocytes. Am J Reprod Immunol. 2001;45(4):205-216. (Pubitemid 32236775)
48. Sulkowski GN, Warren J, Ha CT, Dveksler GS. Characterization of receptors for murine pregnancy specific glycoproteins 17 and 23. Placenta. 2011;32(8):603-610.
49. Huppertz B, Bartz C, Kokozidou M. Trophoblast fusion: fusogenic proteins, syncytins and ADAMs, and other prerequisites for syncytial fusion. Micron. 2006;37(6):509-517. (Pubitemid 44037407)
50. Beristain AG, Zhu H, Leung PC. Regulated expression of ADAMTS-12 in human trophoblastic cells: a role for ADAMTS-12 in epithelial cell invasion? PLoS One. 2011;6(4):e18473.
51. Redline RW, et al. Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2004;7(3):237-249. (Pubitemid 38859152)
52. Glaire MA, El-Omar EM, Wang TC, Worthley DL. The mesenchyme in malignancy: A partner in the initiation, progression and dissemination of cancer. Pharmacol Ther. 2012;136(2):131-141.
53. Hubel CA, Roberts JM. Metabolic syndrome and preeclampsia. In: Lindheimer MD, Roberts JM, Cunningham FG, eds. Chesley's Hypertensive Disorders in Pregnancy. 3rd ed. Boston, Massachusetts, USA: Academic Press; 2009:105-128.
54. Harville EW, Viikari JS, Raitakari OT. Preconception cardiovascular risk factors and pregnancy outcome. Epidemiology. 2011;22(5):724-730.
55. Chibber R. Child-bearing beyond age 50: pregnancy outcome in 59 cases "a concern?". Arch Gynecol Obstet. 2005;271(3):189-194. (Pubitemid 40562092)
56. Wright A, et al. Trisomy 21 is associated with variable defects in cytotrophoblast differentiation along the invasive pathway. Am J Med Genet A. 2004;130A(4):354-364. (Pubitemid 39441610)
57. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science. 1997;277(5332):1669-1672. (Pubitemid 27446230)
58. Dey SK. How we are born. J Clin Invest. 2010; 120(4):952-955.
59. George EM, Granger JP. Mechanisms and potential therapies for preeclampsia. Curr Hypertens Rep. 2011;13(4):269-275.
60. Kikuchi K, et al. In vitro and in vivo characterization of a novel semaphorin 3A inhibitor, SM-216289 or xanthofulvin. J Biol Chem. 2003;278(44):42985-42991. (Pubitemid 37345911)
61. Hunkapiller NM, Fisher SJ. Chapter 12. Placental remodeling of the uterine vasculature. Methods Enzymol. 2008;445:281-302.
62. Winn VD, et al. Gene expression profiling of the human maternal-fetal interface reveals dramatic changes between midgestation and term. Endocrinology. 2007;148(3):1059-1079.
63. Conesa A, Nueda MJ, Ferrer A, Talon M. maSig-Pro: a method to identify significantly differential expression profiles in time-course microarray experiments. Bioinformatics. 2006;22(9):1096-1102.
64. Zhou Y, Bellingard V, Feng KT, McMaster M, Fisher SJ. Human cytotrophoblasts promote endothelial survival and vascular remodeling through secretion of Ang2, PlGF, and VEGF-C. Dev Biol. 2003;263(1):114-125. (Pubitemid 37268007)
65. Damsky CH, Fitzgerald ML, Fisher SJ. Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest. 1992;89(1):210-222.